Real Life Evolution of Surgical Approaches in the Management of Endometrial Cancer in Poland
<b>Objective:</b> The primary objective of this study was to evaluate the evolution of surgical approaches in the management of endometrial cancer in Polish tertiary referral hospitals, comparing the use of minimally invasive surgery (MIS) and laparotomy in 2023 versus 2013. <b>Methods:</b> This retrospective observational study analyzed data from tertiary referral centers in Poland. All surgeries performed for apparently early-stage endometrial cancer in 2013 and 2023 were included. <b>Results:</b> A total of 1062 patients were analyzed, with 417 undergoing operations in 2013 and 640 in 2023. In 2013, 92.6% (386/417) of patients underwent laparotomy. By 2023, 80.1% (513/640) of patients were treated using minimally invasive approaches, including laparoscopy (56.2%, 362/640), robotic-assisted laparoscopy (21.7%, 139/640), and vaginal surgery (1.9%, 12/640). No conversions to laparotomy were recorded in 2013. In 2023, 22 conversions occurred-21 in the laparoscopy group (5.8%, 21/362) and one in the vaginal surgery group (8.3%, 1/12). No conversions were reported in the robotic-assisted group. Intraoperative complications were observed in 2.2% (8/362) of laparoscopic cases, and postoperative complications in 4.4% (16/362). In the robotic-assisted group, one intraoperative complication (0.7%) was reported, with no postoperative complications. <b>Conclusions:</b> Over the past decade, there has been a significant shift in the surgical management of endometrial cancer in Poland, with a growing preference for minimally invasive surgery (MIS). The rate of conversion from MIS to laparotomy remains below 6%. Robotic-assisted laparoscopic surgery may offer additional benefits, particularly for obese patients.
Authors
- Pluvio Coronado (ORCID: https://orcid.org/0000-0003-0357-2015)
- Krzysztof Nowosielski (ORCID: https://orcid.org/0000-0003-1079-8143)
- Marta Ciosek
- Marcin Misiek (ORCID: https://orcid.org/0000-0002-6773-6093)
- Kaja Skowronek (ORCID: https://orcid.org/0000-0001-6705-9072)
- Paweł Sadłecki (ORCID: https://orcid.org/0000-0001-8355-2553)
- Rafał Stojko (ORCID: https://orcid.org/0000-0002-5141-1016)
- Mariusz Bidziński (ORCID: https://orcid.org/0000-0003-4767-6369)
- Krzysztof Jabłoński
- Agnieszka Rychlik (ORCID: https://orcid.org/0000-0002-8860-8883)
- Grzegorz Szewczyk (ORCID: https://orcid.org/0000-0003-4143-2777)
- Rafał Tarkowski (ORCID: https://orcid.org/0000-0001-6926-5419)
- Tomasz Kluz (ORCID: https://orcid.org/0000-0002-4798-3986)
- Katarzyna Pasicz (ORCID: https://orcid.org/0000-0002-3607-0794)
- Anna Bogaczyk (ORCID: https://orcid.org/0009-0008-8816-0290)
- Michał Skuza (ORCID: https://orcid.org/0009-0007-6537-108X)
- Tomasz Łatkiewicz
- Anna Woińska-Przekwas
Institutions
- Gynecologic Oncology Group (US)
- Medical University of Lublin (PL)
- Bydgoszcz University of Science and Technology (PL)
- Holy Family Hospital (IN)
- Medical University of Silesia (PL)
- University of Siedlce (PL)
- Hospital Clínico San Carlos (ES)
- Klinik Hietzing (AT)
- University of Computer Sciences and Economics in Olsztyn (PL)
- National Institute of Oncology (HU)
- Holy Cross University (PL)
- Hospital of the Brothers of St. John of God (AT)
- Postgraduate School of Molecular Medicine (PL)
- Narodowy Instytut Leków (PL)
- AGH University of Krakow (PL)
- University of Rzeszów (PL)
Publication Details
- Journal
- Cancers
- Published
- 2025-08-11
- DOI
- https://doi.org/10.3390/cancers17162626
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00